(Q38579928)

English

Interim results from a phase 3 Ebola vaccine study in Guinea

scientific article published on August 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

4 September 2017

Interim results from a phase 3 Ebola vaccine study in Guinea (English)

1 reference

stated in

Europe PubMed Central

4 September 2017

0 references

2014 Ebola virus epidemic in Guinea

0 references

Orthoebolavirus zairense

0 references

author name string

Philip R Krause

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

26335862

retrieved

4 September 2017

language of work or name

English

0 references

publication date

1 August 2015

1 reference

stated in

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

386

1 reference

stated in

Europe PubMed Central

4 September 2017

831-833

1 reference

stated in

Europe PubMed Central

4 September 2017

9996

1 reference

stated in

Europe PubMed Central

4 September 2017

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900002-1

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(15)00002-1

1 reference

stated in

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

PubMed ID

26335862

retrieved

4 September 2017

(Q38579928)

Interim results from a phase 3 Ebola vaccine study in Guinea

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)